Latest Monoclonal antibodies Stories
FIRST OF SEVERAL PHASE 3 TRIALS TO REPORT RESULTS INDIANAPOLIS, Dec.
DELHI, India, December 9, 2014 /PRNewswire/ -- Access to this therapy will impact 12 million people suffering from auto immune disorders like rheumatoid arthritis,
SAN DIEGO, Dec. 8, 2014 /PRNewswire/ -- Sorrento Therapeutics, Inc.
SAN FRANCISCO, Dec.
MONROVIA, Calif., Dec. 4, 2014 /PRNewswire/ -- Xencor, Inc.
ROCHESTER, N.Y., Dec. 3, 2014 /PRNewswire/ -- Vaccinex Inc. announced today that Dr.
Conference Call Scheduled for Wednesday, December 3rd to Provide Investor Update SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- Lpath, Inc.
ROCHESTER, N.Y., Dec.
- A transitional zone between two communities containing the characteristic species of each.
More Images (1 images) »